Skip to content

Periurethral injection of autologous adipose-derived stem cells from liposuction for the treatment of stress urinary incontinence

Periurethral injection of autologous adipose-derived stem cells from liposuction for the treatment of stress urinary incontinence - Autologous adipose-derived stem cells for the treatment of stress urinary

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000006116
Enrollment
30
Registered
2011-08-04
Start date
2011-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stress urinary incontinence

Interventions

Periurethral injection of autologous adipose-derived stem cells from liposuction for the treatment of stress urinary incontinence

Sponsors

Department of Urology, Nagoya University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 intractable postprostatectomy SUI with the radicality 2 SUI by transurethral resection of prostate by electric or laser divices 3 Female true SUI

Exclusion criteria

Exclusion criteria: no informed consent from the patient One's reemaining days less than 1 year by the complication History of maniglancy less than 5 years or the possibility The possibiliy of recurrence of prostatic cancer Bacterial or viral(HCV, HB, Wa-R,HIV)infection Severe renal or liver damage Severe hematopoietic disease or anemia The possibility of pregnancy Inappropriate judgement by attending physician

Design outcomes

Primary

MeasureTime frame
Evaluation of improvement of SUI Evaluation of safety

Secondary

MeasureTime frame
Evaluation of imaging including blood flow

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026